McKesson

YTD

ALL

Trade McKesson 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About MCK

McKesson Corp. engages in providing healthcare services. It operates through the following segments: North American Pharmaceutical, Oncology and Multispecialty, Prescription Technology Solutions (RxTS), and Medical-Surgical Solutions.

CEO

Brian Scott Tyler

CEOBrian Scott Tyler

Employees

43,000

Employees43,000

Headquarters

Irving, Texas

HeadquartersIrving, Texas

Founded

1833

Founded1833

Employees

43,000

Employees43,000

MCK Key Statistics

Market cap

106.77B

Market cap106.77B

Price-Earnings ratio

21.56

Price-Earnings ratio21.56

Dividend yield

0.40%

Dividend yield0.40%

Average volume

1.18M

Average volume1.18M

High today

$889.69

High today$889.69

Low today

$864.38

Low today$864.38

Open price

$866.71

Open price$866.71

Volume

1.48M

Volume1.48M

52 Week high

$999.00

52 Week high$999.00

52 Week low

$637.00

52 Week low$637.00

Stock Snapshot

With a market cap of 106.77B, McKesson(MCK) trades at $869.58. The stock has a price-to-earnings ratio of 21.56 and currently yields dividends of 0.40%.

During the trading session on 2026-08-08, McKesson(MCK) shares reached a daily high of $889.69 and a low of $864.38. At a current price of $869.58, the stock is +0.6% higher than the low and still -2.3% under the high.

Trading volume for McKesson(MCK) stock has reached 1.48M, versus its average volume of 1.18M.

The stock's 52-week range extends from a low of $637.00 to a high of $999.00.

MCK News

Benzinga 15h

$1000 Invested In McKesson 5 Years Ago Would Be Worth This Much Today - Benzinga

...

TipRanks 22h

McKesson price target raised to $977 from $966 at Morgan Stanley

Morgan Stanley analyst Erin Wright raised the firm’s price target on McKesson (MCK) to $977 from $966 and keeps an Overweight rating on the shares. Unlock powe...

Simply Wall St 1d

McKesson Stock Pauses Despite Higher Guidance And EPS Strength

McKesson stock barely flinched after earnings, slipping about 1% from its recent highs, even though the company just posted the kind of pharmaceutical distribut...

Analyst ratings

86%

of 21 ratings

Buy

85.7%

Hold

14.3%

Sell

More MCK News

Simply Wall St 2d

Is McKesson’s Revenue Growth With Falling EPS Altering The Investment Case For McKesson?

McKesson Corporation has reported past first-quarter 2026 results, with sales rising to US$105.38 billion from US$97.83 billion a year earlier, while net income...

Barron's 3d

Healthcare Stocks Have Been Forgotten. Eli Lilly, McKesson, and 9 More to Buy.

Healthcare Healthcare Stocks Have Been Forgotten. Eli Lilly, McKesson, and 9 More to Buy. In this article XLV LLY VRTX GILD MCK Many healthcare and pharmaceutic...

Simply Wall St 7d

McKesson Declares Quarterly Dividend, Is The Stock Still Undervalued?

McKesson (MCK) recently declared a quarterly dividend of US$0.94 per share, payable on October 1, 2026, with the ex dividend and record dates set for September...

People also own

Based on the portfolios of people who own MCK. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.